In vitro activity and cytotoxicity of Crocus sativus extract against leihmania major (MRHO/IR/75/ER)

Infectious Disorders - Drug Targets

Volumn 14, Issue 1, 2014, Pages 56-60

  Yousefi, Elham ^a   Eskandari, Alborz ^a   Gharavi, Mohammad Javad ^b   Khademvatan, Shahram ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cell death; Crocus sativus; Leishmania major; Saffron

Indexed keywords

CROCUS SATIVUS EXTRACT; PHOSPHATIDYLSERINE; ANTIPARASITIC AGENT; PLANT EXTRACT;

AGAR GEL ELECTROPHORESIS; AMASTIGOTE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DOSE RESPONSE; DRUG ACTIVITY; ED50; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; IC50; LEISHMANIA MAJOR; LEISHMANIASIS; MICROSCOPY; MTT ASSAY; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PISTIL STIGMA; PROMASTIGOTE; CHEMISTRY; CROCUS; DRUG EFFECTS; DRUG SENSITIVITY; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; LEISHMANIASIS, CUTANEOUS; LIFE CYCLE STAGE; MEDICINAL PLANT; METABOLISM; PARASITOLOGY; PHYTOTHERAPY; TIME FACTOR;

ANTIPARASITIC AGENTS; APOPTOSIS; CROCUS; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LIFE CYCLE STAGES; PARASITIC SENSITIVITY TESTS; PHOSPHATIDYLSERINES; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; TIME FACTORS;

EID: 84926296721     PISSN: 18715265     EISSN: 18755852     Source Type: Journal    
DOI: 10.2174/1871526514666140827101901     Document Type: Article

References (23)

1. [1] Shaw, J. The leishmaniases-survival and expansion in a changing world. A mini-review. Memórias do Instituto Oswaldo Cruz., 2007, 102, 541-7.
2. [2] Postigo, J.A. Leishmaniasis in the World Health Organization Eastern Mediterranean Region. Int. J. Antimicrob. Agents, 2010, 36, 62-5.
3. [3] Fuertes, A.M.; Nguewa, A.P.; Castilla, J.; Carlos, A.; Pérez, J.M. Anticancer compounds as leishmanicidal drugs: challenges in chemotherapy and future perspectives. Current Medicinal Chemistry, 2008, 15, 433-9.
4. [4] W.H.O. Control of the leishmaniases. Geneva; 2010.
5. [5] Verma, A.; Srivastava, S.; Sane, S.A.; Marrapu, V. K.; Srinivas, N.; Yadav, M.; Bhandari, K.; Gupta, S. Antileishmanial activity of benzocycloalkyl azole oximino ethers: The conformationally conspeciest analogues of oxiconazole. Acta Tropica, 2011, 117, 157-60
6. [6] Saha, P.; Mukhopadhyay, D.; Chatterjee, M. Immunomodulation by chemotherapeutic agents against Leishmaniasis. Int. Immunopharmacol., 2011, 11, 1668-79.
7. [7] Abdullaev, F.I.; Biological effects of saffron. Biofactors, 1993, 4, 83-6.
8. [8] Abdullaev, F.I. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp. Biol. Med. Maywood, 2002, 227, 20-5.
9. [9] Tavakkol-Afshari, J.; Brook, A.; Mousavi, S.H. Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. Food Chem. Toxicol., 2008, 46, 3443-7.
10. [10] Abdullaev, F.I.; Espinosa, J.; Aguirre, J. Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials, Cancer Detection Prev., 2004, 28, 430-6.
11. [11] Hosseinpour-Chermahini, S.; Adibah Abd, F.M.; Roji Sarmidi, M.; Taghizadeh, E.; Salehnezhad, S. Impact of saffron as an anti-cancer and anti-tumor herb. AJPP, 2010, 4, 834-40.
12. [12] Khademvatan, S.; Adibpour, N.; Eskandari, A.; Rezaee, S.; Hashemitabar, M.; Rahim, F. In silico and in vitro comparative activity of novel experimental derivatives against Leishmania major and Leishmania infantum promastigotes. Exp. Parasitol., 2013, 135, 208-16.
13. [13] Khademvatan, S.; Gharavi, M.J.; Rahim, F.; Saki, J.; Miltefosineinduced apoptotic cell death on Leishmania major and L. tropica species. Korean J. Parasitol., 2011, 49, 17-23.
14. [14] Postigo, J.A.; Leishmaniasis in the World Health Organization Eastern Mediterranean Region. Int. J. Antimicrob. Agents, 2010, 36, 62-5.
15. [15] Oshaghi, M.A.; Rasolian, M.; Shirzadi, M.R.; Mohtarami, F.; Doosti, S.; First report on isolation of Leishmania tropica from sandflies of a classical urban Cutaneous leishmaniasis focus in southern Iran. Exp. Parasitol., 2010, 126, 445-50.
16. [16] Iran Ministry of Health & Medical Education (IMHME), Official Report of Leishmania cases in Iran, 2009.
17. [17] Chakravarty, J.; Sundar, S.; Drug resistance in leishmaniasis. J. Glob. Infect. Dis., 2010, 2 (2), 167-76.
18. [18] Maltezou, H.C.; Drug resistance in visceral leishmaniasis. J. Biomed. Biotechnol., 2010, 617521.
19. [19] Polonio, T.; Efferth, T. Leishmaniasis: drug resistance and natural products (Review). Int. J. Mol. Med., 2008, 22 (3), 277-86.
20. [20] Fuertes, M.A.; Nguewa, P.A.; Castilla, J.; Alonso, C.; Perez, J.M. Anticancer compounds as leishmanicidal drugs: challenges in chemotherapy and future perspectives. Curr. Med. Chem., 2008, 15 (5), 433-9.
21. [21] Bathaie, S.Z.; Mousavi, S.Z. New applications and mechanisms of action of saffron and its important ingredients. Crit. Rev. Food Sci. Nutr., 2010, 50, 761-86.
22. [22] Bakhshi, H.; Sam, S.; Rozati, R.; Sultan, P.; Islam Rathor B. DNA fragmentation and cell cycle areest: A hallmark of apoptosis induced by crocin from kashmiri saffron in a human pancreatic cancer cell line. Asian. Pac. J. Cancer. Prev., 2010, 11(10), 2-9.
23. [23] Bagherani, N. Can saffron (Crocus sativus) be effective in the treatment of Leishmaniasis?, IDDT, 2013, 13, 328-9.